feed,title,long_url,short_url
SeekingAlpha,"Ardelyx rises ~10% as FDA grants appeal for kidney disease drug, refiling plans in H1 2023",https://seekingalpha.com/news/3921108,
SeekingAlpha,Wall Street Breakfast: What A Year!,https://seekingalpha.com/article/4566870,
